Pictet Asset Management (Switzerland)’s Vanda Pharmaceuticals VNDA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10.3M	Buy	1,565,209 +347,392	+29%	+$2.23M	0.01%	613
2023 Q1	$8.27M	Buy	1,217,817 +761,200	+167%	+$5.35M	0.01%	660
2022 Q4	$3.37M	Buy	456,617 +113,627	+33%	+$1.11M	﹤0.01%	832
2022 Q3	$3.39M	Buy	342,990 +58,601	+21%	+$619K	0.01%	819
2022 Q2	$3.1M	Buy	284,389 +65,207	+30%	+$676K	﹤0.01%	863
2022 Q1	$2.48M	Hold	219,182	–	–	﹤0.01%	938
2021 Q4	$3.44M	Sell	219,182 -28,454	-11%	-$496K	﹤0.01%	910
2021 Q3	$4.24M	Buy	+247,636	New	+$4.34M	﹤0.01%	870

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s VNDA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Vanda Pharmaceuticals (VNDA) stake by 29% in Q2 2023, buying an estimated $2.23M and bringing the position to 1,565,209 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #613.

Pictet Asset Management (Switzerland) first reported a position in VNDA in Q3 2021 and has held it in 8 quarters since. 188 funds tracked by Wall St. Rank hold VNDA as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,565,209 shares of Vanda Pharmaceuticals worth $10.3M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 347,392 Vanda Pharmaceuticals shares in Q2 2023, an estimated $2.23M.
Vanda Pharmaceuticals made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #613 holding.
Pictet Asset Management (Switzerland) first reported a position in Vanda Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
188 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.